Veracyte Stock Analysis

Veracyte Stock Analysis Notes

About 99.0% of the company outstanding shares are owned by institutional investors. The book value of Veracyte was at this time reported as 15.12. The company had not issued any dividends in recent years. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis Prosigna Breast Cancer Assay for breast cancer diagnosis Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis and Immunoscore Colon Cancer test for colon cancer diagnosis. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Veracyte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 761 people. For more information please call Bonnie Anderson at 650 243 6300 or visit https://www.veracyte.com.

Veracyte Investment Alerts

Veracyte Upcoming and Recent Events

Veracyte Largest EPS Surprises

View All Earnings Estimates

Veracyte Environmental, Social, and Governance (ESG) Scores

Veracyte Thematic Classifications

Veracyte Stock Institutional Investors

Note, although Veracyte's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Veracyte Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.43 B.

Veracyte Profitablity

The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Management Efficiency

Veracyte has return on total asset (ROA) of 0.0139 % which means that it generated a profit of $0.0139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0218 %, meaning that it created $0.0218 on every $100 dollars invested by stockholders. Veracyte's management efficiency ratios could be used to measure how well Veracyte manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.06 in 2025. Return On Capital Employed is likely to gain to 0.01 in 2025. At this time, Veracyte's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 1.4 B in 2025, whereas Non Current Liabilities Other is likely to drop slightly above 923.4 K in 2025.

Technical Drivers

As of the 20th of March, Veracyte has the Coefficient Of Variation of (814.51), variance of 11.83, and Risk Adjusted Performance of (0.10). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Veracyte, as well as the relationship between them.

Veracyte Price Movement Analysis

Veracyte Insider Trading Activities

Veracyte Outstanding Bonds

Veracyte Predictive Daily Indicators

Veracyte Corporate Filings

Veracyte Forecast Models

Veracyte's time-series forecasting models are one of many Veracyte's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Veracyte's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Veracyte prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Veracyte shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Veracyte. By using and applying Veracyte Stock analysis, traders can create a robust methodology for identifying Veracyte entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Veracyte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Veracyte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Veracyte stock analysis indicators help investors evaluate how Veracyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Veracyte shares will generate the highest return on investment. By understating and applying Veracyte stock analysis, traders can identify Veracyte position entry and exit signals to maximize returns.

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.